Included in the formulation
Included in the list (Order of the Government of the Russian Federation No. 2782-r of 30.12.2014):VED
АТХ:J.06.B.B.05 Immunoglobulin human anti-rabies
Pharmacodynamics:Contains specific antibodies that neutralize rabies virus.
Pharmacokinetics:After intramuscular injection, the maximum concentration in the blood plasma is achieved after 2-3 days.
The half-life is 3-4 weeks.
Indications:It is used in combination with an antirabic vaccine to prevent the development of rabies in patients with hydrophobia who have undergone multiple bites of rabid animals suspected of rabies.
XXI.Z20-Z29.Z24.2 The need for immunization against rabies
XXI.Z20-Z29.Z29.1 Prophylactic immunotherapy
Contraindications: None.With individual intolerance, premedication with glucocorticoids or antihistamines is performed.
Carefully:Increased individual sensitivity.
Pregnancy and lactation:Recommendations for FDA - category is not defined. It is used for life indications.
Dosing and Administration:Once, intramuscularly: children - in anterolateral hip surface, adults - in the upper outer quadrant of the buttocks; on 20 IU / kg of weight. Most of the drug is injected directly into the bites - deep into the wound and around it.
Side effects:Local Reactions: swelling and hyperemia at the injection site.
Allergic reactions.
Overdose:Cases of overdose are not described.
Treatment is symptomatic.
Interaction:Not described.
Special instructions:The drug should be administered no later than 7 days after contact with the animal. Intravenous administration of the drug is prohibited.
Rules for combined treatment and prevention of rabies: first introduced anti rabies immunoglobulin, then no sooner than 30 minutes - rabies vaccine (using different syringes).